136 results
Page 3 of 7
6-K
EX-99.1
xjn19zkb 3u
24 Mar 22
InflaRx Reports Full Year 2021 Financial and Operating Results
8:40am
6-K
EX-99.1
w49xl9z6uf8x3
17 Mar 22
InflaRx Receives Corrected Advice Letter from FDA Related to Phase III Program for Vilobelimab in Hidradenitis Suppurativa
7:30am
6-K
EX-99.1
6pswvdfh8umwuq
8 Mar 22
InflaRx Announces Vilobelimab Trial in Pyoderma Gangrenosum Selected for Late-Breaker Oral Presentation at 2022 AAD Annual Meeting
7:51am
6-K
EX-99.1
06qjxwmn1m3vt032y51b
28 Feb 22
InflaRx Provides Update on Development Plans for Vilobelimab in Hidradenitis Suppurativa
7:30am
6-K
EX-99.1
0g5 qvg5w7
16 Feb 22
InflaRx Reports Progress in Ongoing Phase II Clinical Trial with Vilobelimab in Cutaneous Squamous Cell Carcinoma
7:30am
6-K
EX-99.1
178big
10 Jan 22
InflaRx Announces New Pipeline Program – Oral C5aR Inhibitor
7:30am
6-K
EX-99.2
l9o7ak7 ntwg
10 Jan 22
InflaRx Announces New Pipeline Program – Oral C5aR Inhibitor
7:30am
6-K
EX-99.1
ufwrop
5 Jan 22
Current report (foreign)
7:30am
6-K
EX-99.2
ig3aciha
15 Nov 21
Current report (foreign)
7:36am
6-K
EX-99.1
m0ed49nl
15 Nov 21
Current report (foreign)
7:36am
6-K
EX-99.3
tkf5i2 3n
5 Nov 21
Current report (foreign)
7:30am
6-K
EX-99.2
ame8v b07t4hf3tzs
5 Nov 21
Current report (foreign)
7:30am
6-K
EX-99.2
tcpcvpfa
27 Oct 21
InflaRx Announces Positive Data from Third Cohort of Phase IIa Open-Label Study with Vilobelimab in Pyoderma Gangraenosum
7:31am
6-K
EX-99.1
fjyx1pug7np80
27 Oct 21
InflaRx Announces Positive Data from Third Cohort of Phase IIa Open-Label Study with Vilobelimab in Pyoderma Gangraenosum
7:31am
6-K
EX-99.1
htgyb bdrz
19 Oct 21
Current report (foreign)
7:30am
6-K
EX-99.1
l9g3gff ebsv7te02
12 Oct 21
InflaRx Completes Enrollment of Vilobelimab Phase III Study in Severe COVID-19
7:30am
6-K
EX-99.1
l9159x
8 Sep 21
InflaRx to Proceed with Pivotal Development for Vilobelimab in Hidradenitis Suppurativa with New Primary Endpoint
7:30am
6-K
EX-99.1
aaobbj95n
10 Aug 21
InflaRx Announces Positive Data from Second Interim Analysis
7:30am
6-K
EX-99.2
bipmwoxbs6s
5 Aug 21
Current report (foreign)
8:23am